Literature DB >> 8490841

Myxopapillary ependymoma. Results of nucleolar organizing region staining.

D A Ross1, P E McKeever, H M Sandler, K M Muraszko.   

Abstract

BACKGROUND: Although myxopapillary ependymomas are generally benign with a tendency for slow growth and local recurrence, they are capable of spread within the nervous system and of extraneural metastasis. Histologic features have not been helpful in determining which patients are at risk for recurrence or dissemination, making management decisions difficult.
METHODS: A retrospective review was conducted of 14 cases of myxopapillary ependymoma. The nucleolar organizing region (NOR) staining method was used to determine if this technique was useful in the management of these tumors.
RESULTS: Five patients had total resections of encapsulated lesions, four had total resections of adherent tumors, and four had subtotal resections. Twelve received postoperative radiation therapy. With a mean follow-up of 80 months, 12 patients are well and disease-free. Two patients have had recurrences after surgery and irradiation, leading to death in one and disability in the other. The mean number of NOR per cell in eight specimens ranged from 0.4-1.64. The patient who died with intracranial spread had the highest number of NOR per cell.
CONCLUSIONS: Based on these data and a review of the literature, it is recommended that radiation be delayed until recurrence in tumors that have been totally resected. Local radiation therapy may be indicated in subtotally resected tumors. NOR staining shows promise in predicting the likelihood of spread of tumor. Patients with myxopapillary ependymomas should be followed indefinitely because of the potential for late recurrence, even after aggressive therapy.

Entities:  

Mesh:

Year:  1993        PMID: 8490841     DOI: 10.1002/1097-0142(19930515)71:10<3114::aid-cncr2820711036>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  The nature of double concomitant myxopapillary ependymoma: report of a case.

Authors:  J Francisco Salomão; Cecília Vianna de Andrade; Antonio Rosa Bellas; Tatiana Protzenko Cervante
Journal:  Childs Nerv Syst       Date:  2013-08-01       Impact factor: 1.475

2.  Management of pediatric myxopapillary ependymoma: the role of adjuvant radiation.

Authors:  Harold C Agbahiwe; Moody Wharam; Sachin Batra; Kenneth Cohen; Stephanie A Terezakis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-17       Impact factor: 7.038

3.  Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network.

Authors:  Damien C Weber; Yucai Wang; Robert Miller; Salvador Villà; Renata Zaucha; Alessia Pica; Philip Poortmans; Yavuz Anacak; Gokhan Ozygit; Birgitta Baumert; Guy Haller; Matthias Preusser; Jing Li
Journal:  Neuro Oncol       Date:  2014-10-09       Impact factor: 12.300

4.  Pediatric Spinal Ependymomas.

Authors:  Özden Erhan Sofuoğlu; Anas Abdallah
Journal:  Med Sci Monit       Date:  2018-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.